NEW YORK, NY–(Marketwire – March 8, 2010) – NewCardio, Inc. (
Further information:
Related posts:
- Trimedyne’s Chairman Interviewed by CEO/CFO
- Entest BioMedical, Inc. Chairman & CEO Addressed Shareholders on Its New Company Blog Site Regarding COPD and Immunotherapeutic Cancer Vaccine
- HemaCare Names van der Wal President and CEO
- Proteonomix, Inc. (PROT) Announces That Michael Cohen, Its President, Was Interviewed on a Medical Television Show Broadcast Throughout Central and South America
- InfuSystem Holdings Reports $10.7 Million of Revenue and $3.2 Million of Adjusted EBITDA for the Fourth Quarter of 2009

Posted in